Download Blood cells in nuclear medicine, part I: Cell kinetics and by M. L. Thakur (auth.), Max R. Hardeman PhD, Yves Najean MD PDF

By M. L. Thakur (auth.), Max R. Hardeman PhD, Yves Najean MD (eds.)

Show description

Read Online or Download Blood cells in nuclear medicine, part I: Cell kinetics and bio-distribution PDF

Similar nuclear books

All About History: The World’s Worst Disasters

All approximately historical past is the stunningly realised new journal from the makers of ways it really works and All approximately area. that includes attractive illustrations, photographs and portraits depicting every thing from historical civilisations to the chilly warfare, All approximately background is out there and wonderful to all and makes background enjoyable for the total relations.

Advances in Nuclear Science and Technology, Volume 23

Quantity 23 makes a speciality of perturbation Monte Carlo, non-linear kinetics, and the move of radioactive fluids in rocks.

Nuclear and Particle Physics: The Changing Interface

"Nuclear and Particle Physics" either were very exact topics for many years, and at the moment are constructing a growing number of interfaces. hence, hitherto ordinary tools of particle physics are followed via nuclear physics. The authors attempt to construct bridges among either fields and provides nuclear physicists an intensive creation from the basics of particle physics to present study during this box.

Additional info for Blood cells in nuclear medicine, part I: Cell kinetics and bio-distribution

Sample text

Comparison of recovery , survival and organ uptake of 111 Inlabelled autologous platelets in 3 asplenic patients and in 6 normal subjects. Recovery Mean life span Liver/heart ratio at 20 min. (%) gamma function (days) of activity at 20 min. 02. The radioactivity of the 3 selected areas, 40 expressed as a percentage of total activity is shown in table 2. The liver activity is not higher than the precordial activity at 20 min. On day 5, the liver activity is very slightly elevated compared to the precordial activity.

N. McCOLLUM INTRODUCTION Since the introduction of lipid soluble chelates of 111 In as cell labelling agents (1) there have been a large number of reports on the in vivo and in vitro uses of Indium labelled platelets derived from man and laboratory animals. Such labelled cells have been used for the determination of deep vein thrombosis (2) renal transplant rejection and associated problems (3) and the detection of thrombogenicity in prosthetic arterial graft materials (4). Animal models have been used to evaluate prosthetic materials and medical plastics (5) drug regimes (6) and drug induced normalisation of platelet survival (7).

S. 5; 250 mOsm). 5, citrate 22 mM). yrode-albumine solution. Tyrode solution is prepared sterile and apyrogen from stock solutions. s. 100 mI. s. 100 mI. s. 100 ml. s. 100 mI. 3 and osmolarity to 295 mOsm. c) Prostacyclin (PGI 2 ). s. 36 at 4°C). 1 ml aliquots and kept at -30°C for at least 6 months. 2. Radioactive products. lllIndium oxinate (Ref. IN-15P) and 3H-5-hydroxytryptamine (Ref. TRK 223) were obtained from Amersham and 125I-albumine (Ref. SARI 125 A2 3. Platelet aggregating~gents ) from CIS, France.

Download PDF sample

Rated 4.01 of 5 – based on 42 votes